Search research articles
Contact Us
Filters
Showing results (41-50 of 117) with videos related to
Page
of 12
Sort By:
Cellular and Molecular Life Sciences : CMLS
|
July 21, 2022
ISG15 as a prognostic biomarker in solitary fibrous tumour
Jose L Mondaza-Hernandez, David S Moura, María Lopez-Alvarez, et al.
Cytokine
|
February 16, 2024
Circulating TNF-RII, IP-10 and HGF are associated with severity of COVID-19 in oncologic patients
Jaime Carrillo-García, Serena Lacerenza, Nadia Hindi, et al.
Eclinicalmedicine
|
September 21, 2023
An interpretable AI model for recurrence prediction after surgery in gastrointestinal stromal tumour: an observational cohort study
Dimitris Bertsimas, Georgios Antonios Margonis, Seehanah Tang, et al.
Cancer Letters
|
May 23, 2026
NAB2::STAT6 Fusion Proteins Drive Nuclear Condensate Formation and Transcriptional Reprogramming in Solitary Fibrous Tumors
Yi Li, Jose L Mondaza-Hernandez, Gauthami Pulivendala, et al.
British Journal of Cancer
|
August 30, 2017
Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinib
Heikki Joensuu, Jean-Yves Blay, Alessandro Comandone, et al.
Future Oncology (London, England)
|
February 11, 2025
SaLudo: a randomized phase IIb/III study of lurbinectedin plus doxorubicin as first-line treatment in leiomyosarcoma
Gregory M Cote, Sant P Chawla, George Demetri, et al.
Journal of Surgical Oncology
|
August 25, 2022
A prospective real-world study of the diffuse-type tenosynovial giant cell tumor patient journey: A 2-year observational analysis
Nicholas M Bernthal, John H Healey, Emanuela Palmerini, et al.
Annals of Surgical Oncology
|
January 23, 2015
Role of surgery in patients with recurrent, metastatic, or unresectable locally advanced gastrointestinal stromal tumors sensitive to imatinib: a retrospective analysis of the Spanish Group for Research on Sarcoma (GEIS)
Jordi Rubió-Casadevall, Javier Martinez-Trufero, Xabier Garcia-Albeniz, et al.
Therapeutic Advances in Medical Oncology
|
January 30, 2024
Trabectedin and low-dose radiation therapy in patients with advanced leiomyosarcoma
Javier Martin-Broto, Alicia Olarte-García, Ricardo Fernandéz-Rodríguez, et al.
Pharmaceuticals (Basel, Switzerland)
|
December 31, 2025
VEGF Signaling Pathway Germline Polymorphisms as Prognostic Pharmacogenetic Biomarkers in Localized High-Grade Osteosarcoma Patients from the GEIS-33 Protocol
Juliana Salazar, María J Arranz, Javier Martin-Broto, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 117) with videos related to
Sort By:
Page
of 12
Cellular and Molecular Life Sciences : CMLS
|
July 21, 2022
ISG15 as a prognostic biomarker in solitary fibrous tumour
Jose L Mondaza-Hernandez, David S Moura, María Lopez-Alvarez, et al.
Cytokine
|
February 16, 2024
Circulating TNF-RII, IP-10 and HGF are associated with severity of COVID-19 in oncologic patients
Jaime Carrillo-García, Serena Lacerenza, Nadia Hindi, et al.
Eclinicalmedicine
|
September 21, 2023
An interpretable AI model for recurrence prediction after surgery in gastrointestinal stromal tumour: an observational cohort study
Dimitris Bertsimas, Georgios Antonios Margonis, Seehanah Tang, et al.
Cancer Letters
|
May 23, 2026
NAB2::STAT6 Fusion Proteins Drive Nuclear Condensate Formation and Transcriptional Reprogramming in Solitary Fibrous Tumors
Yi Li, Jose L Mondaza-Hernandez, Gauthami Pulivendala, et al.
British Journal of Cancer
|
August 30, 2017
Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinib
Heikki Joensuu, Jean-Yves Blay, Alessandro Comandone, et al.
Future Oncology (London, England)
|
February 11, 2025
SaLudo: a randomized phase IIb/III study of lurbinectedin plus doxorubicin as first-line treatment in leiomyosarcoma
Gregory M Cote, Sant P Chawla, George Demetri, et al.
Journal of Surgical Oncology
|
August 25, 2022
A prospective real-world study of the diffuse-type tenosynovial giant cell tumor patient journey: A 2-year observational analysis
Nicholas M Bernthal, John H Healey, Emanuela Palmerini, et al.
Annals of Surgical Oncology
|
January 23, 2015
Role of surgery in patients with recurrent, metastatic, or unresectable locally advanced gastrointestinal stromal tumors sensitive to imatinib: a retrospective analysis of the Spanish Group for Research on Sarcoma (GEIS)
Jordi Rubió-Casadevall, Javier Martinez-Trufero, Xabier Garcia-Albeniz, et al.
Therapeutic Advances in Medical Oncology
|
January 30, 2024
Trabectedin and low-dose radiation therapy in patients with advanced leiomyosarcoma
Javier Martin-Broto, Alicia Olarte-García, Ricardo Fernandéz-Rodríguez, et al.
Pharmaceuticals (Basel, Switzerland)
|
December 31, 2025
VEGF Signaling Pathway Germline Polymorphisms as Prognostic Pharmacogenetic Biomarkers in Localized High-Grade Osteosarcoma Patients from the GEIS-33 Protocol
Juliana Salazar, María J Arranz, Javier Martin-Broto, et al.
Page
of 12